Nirlac Biotec Private Limited - Due diligence report

A 360° intelligence report on Nirlac Biotec Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

1993-07-28 Mumbai, Maharashtra Converted To Llp Unlisted Active Compliant
Share
NB Nirlac Biotec Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Nirlac Biotec Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
40/100
Trust Score
Caution Indicated

Nirlac Biotec Private Limited is assessed as Caution Indicated with a Trust Score of 40/100. Nirlac Biotec Private Limited is a private limited indian non-government company incorporated in 1993, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Nirlac Biotec Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
40/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
25/100
No active directors on record.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
25/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 30/100 Caution Indicated
  • Company status is "Converted To Llp" - not Active.
  • Last balance sheet is for Mar 2020 - filings overdue.
05

Director Intelligence

Stability score: 25/100
No active directors on record.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 25
Growth signals & trust indicators
Operating for 32+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
Adverse company status: Converted To Llp.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence32/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment42/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view40/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 8 events
20 Oct 2020
Director ceased
NIRMAL LALCHAND JAIN
Director ceased
KARTIK JAIN NIRMAL
Director ceased
BHAVIK NIRMAL JAIN
30 Sep 2020
Last AGM held
Annual general meeting
31 Mar 2020
Latest balance sheet
Filed with ROC
20 Dec 2008
Director ceased
ARTI NIRMALKUMAR JAIN
24 Nov 2008
Director ceased
SURESH RANCHODDAS SANGHAVI
28 Jul 1993
Incorporated
Registered with Roc Mumbai
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
Net worth is positive.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Casper Vinimay Private Limited U65923WB2008PTC122112 Kolkata, West Bengal, India
Prime Intercorp Private Limited U51909MP2019PTC048856 Indore, Madhya Pradesh, India
Aruna Seeds Private Limited U01122TG1995PTC019739 Hyderabad, Telangana, India
Maplerose Aromas Private Limited U24299MH2018PTC312175 Mumbai, Maharashtra, India
Malnad Jyothi Gas Private Limited U23203KA2001PTC028829 Shimoga, Karnataka, India
Gravidanza9 Private Limited U74999DL2017PTC322308 New Delhi, Delhi, India
Jbh Infraprojects Private Limited U70109WB2010PTC140944 Kolkata, West Bengal, India
Mahaprabhu Commosales Private Limited U51909WB2011PTC163771 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Nirlac Biotec Private Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Nirlac Biotec Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Nirlac Biotec Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 40/100, distress signals and MSME payment-delay disclosures - know whether Nirlac Biotec Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Nirlac Biotec Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Nirlac Biotec Private Limited an active company?

Nirlac Biotec Private Limited has MCA status “Converted To Llp” with a compliance score of 30/100 (Caution Indicated).

Is Nirlac Biotec Private Limited financially healthy?

Nirlac Biotec Private Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Nirlac Biotec Private Limited?

Its overall Trust Score is 40/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Nirlac Biotec Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report.

Does Nirlac Biotec Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Nirlac Biotec Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Nirlac Biotec Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.